Emgality 120 mg
As listed in the register: Emgality 120 mg, solution injectable en stylo prérempli
120 mg ·
- Prescription only
- Pain, sleep, mood, epilepsy and the brain
- Active substance
- Galcanezumabum
- Made by
- Eli Lilly (Suisse) SA
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
- Traitement prophylactique de la migraine
From the official label · 2026-09-30 · Swissmedic
Same active substance, strength and form in other countries
Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.
Medicine passport: one printable page to show a pharmacist abroad
SpainNo exact match for this strength and form
CanadaNo exact match for this strength and form
NetherlandsNo exact match for this strength and form
Details
| Made by | Eli Lilly (Suisse) SA |
|---|---|
| Active substance | Galcanezumabum |
| Used in | Pain, sleep, mood, epilepsy and the brain |
| Strength | 120 mg |
| Classification | N02CD02 · Pain, sleep, mood, epilepsy and the brain |
| Dispensing (as stated by the register) | Abgabekategorie B |
| Name in the register | Emgality 120 mg, solution injectable en stylo prérempli |
| Packs | 1 x 1 ml Injektor(en), vorgefüllt/Pen · 2 x 1 ml Injektor(en), vorgefüllt/Pen |
| Zulassungsnummer | 67026 |
| Dosisstärke | 1 |
Source: Zugelassene Packungen Humanarzneimittel · 2026-09-30 · not reviewed by a clinician
Quelle: Swissmedic. The publisher’s terms do not grant reproduction, so text is shortened and linked. Publisher’s terms.